Use of silver nanoparticles for the treatment of pyorrhea

The Clinical and Anti-inflammatory action of Silver Nanoparticles in the treatment of Chronic Periodontitis - CASN

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/04/018718

Enrollment

Registered

2019-04-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: Silver nanoparticles solution : Concentration- 0.01mg/ml Silver Nanoparticles Dose- 16 ml Method of application- Local drug delivery into the periodontal pocket Frequnecy- Approx. 4

Eligibility

Inclusion criteria

Inclusion criteria: 1. 25-50 years of age 2. Probing pocket depth >= 5mm 3. Systemically healthy patients 4. No history of periodontal therapy in the last 6 months

Exclusion criteria

Exclusion criteria: 1. Smokers 2. Pregnant or lactating women 3. Allergic to silver metal

Design outcomes

Primary

Measure	Time frame
Use of Silver nanoparticles as an adjunct to scaling and root planingTimepoint: 1 month	—

Secondary

Measure	Time frame
Use of Silver nanoparticles as an adjunct to scaling and root planingTimepoint: 3 months	—

Countries

India

Contacts

Public ContactIshita Joshi

King George Medical University

shalinikaushal@kgmcindia.edu9450454408

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026